
Chief Technology Officer
Nick is Chief Technology Officer at Locus Biosciences. As co-founder of EpiBiome, a San Francisco-based, venture-backed biotech company acquired by Locus, Nick brings deep experience in next-generation sequencing, high-throughput automation, and advanced manufacturing technologies. He developed Locus’s platform phage manufacturing process, used to generate drug product for the world’s first clinical trial testing a recombinant bacteriophage therapy. Nick earned his PhD in Chemistry from Stanford University, where he also completed a postdoc in developmental biology.